Press Ventures Launches New Corporate Website Highlighting Biosafety Sector
Donnerstag, 29.08.2013 15:10 von DGAP
Press Ventures, Inc.
29.08.2013 15:05
---------------------------------------------------------------------------
WARSAW, Poland, 2013-08-29 15:05 CEST (GLOBE NEWSWIRE) --
Press Ventures Inc. (OTCQB:PVEN) ('Press Ventures' or the 'Company'), is
pleased to announce the launch of a comprehensive website to effectively
illustrate the Company's new direction into the biosafety market.
'The global urgency for novel biosafety solutions has never been more evident
with recent outbreaks of deadly viruses and bacteria that have claimed numerous
lives,' commented Mr. Edward Denkiewicz, Press Ventures' CEO. 'I am extremely
pleased with how the Company's new website has turned out and I'm confident
that its excellent visuals and striking facts about biosafety will help explain
the sector, our patented technology, as well as the global business opportunity
to investors. I encourage all interested parties to visit the new website to
better understand our story and how we plan to combat viruses and bacteria in a
natural way without the use of any harmful chemicals.'
The new Press Ventures corporate website can be found at
www.biosafetysolutionsinc.com.
About Press Ventures
Press Ventures owns the worldwide rights to the patented Cedar Leaf Oil
Diffusion ('CLO-D') technology for the use of natural non-human harming vapors
to kill bacteria, mold, and viruses in buildings. The patented CLO-D technology
has been shown to be capable of killing many deadly bacterial and viral
substances such as anthrax and H1N1 in buildings while they are still occupied.
The CLO-D technology has been laboratory and field tested and the Company
believes that use of the technology can provide a marked improvement in air
quality and eliminate many of the most dangerous airborne bacteria, viruses,
and pollutants. For additional information about CLO-D technology and Press
Ventures, please visit www.biosafetysolutionsinc.com
Notice Regarding Forward-Looking Statements
This news release contains 'forward-looking statements' as that term is defined
in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e)
of the Securities Exchange Act of 1934, as amended. Statements in this press
release that are not purely historical are forward-looking statements and
include any statements regarding beliefs, plans, expectations or intentions
regarding the future. Such forward-looking statements include, among other
things, demand for natural biosafety solutions, exploitation of business
opportunities, strategic business goals, size of the global market for virus
and bacteria security, rise in diseases, growth of the services sterilization
market, the Company's business and product development plans and projections,
and market information. Actual results could differ from those projected in any
forward-looking statements due to numerous factors. Such factors include, among
others, the inherent uncertainties associated with developing new products or
technologies and operating as a development stage company, our ability to
retain important members of our management team and attract other qualified
personnel, our ability to raise the additional funding we will need to continue
to pursue our business and product development plans, our ability to develop
and commercialize products based on our technology platform, and market
conditions. These forward-looking statements are made as of the date of this
news release, and we assume no obligation to update the forward-looking
statements, or to update the reasons why actual results could differ from those
projected in the forward-looking statements. Although we believe that any
beliefs, plans, expectations and intentions contained in this press release are
reasonable, there can be no assurance that any such beliefs, plans,
expectations or intentions will prove to be accurate. Investors should consult
all of the information set forth herein and should also refer to the risk
factors disclosure outlined in the reports and other documents we file with the
SEC, available at www.sec.gov.
CONTACT: Investor Relations Contact:
1-888-709-1550
IR@kingstonir.net
News Source: NASDAQ OMX
29.08.2013 Dissemination of a Corporate News, transmitted by DGAP -
a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Press Ventures, Inc.
United States
Phone:
Fax:
E-mail:
Internet:
ISIN: US74112U2024
WKN:
End of Announcement DGAP News-Service
---------------------------------------------------------------------------